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Ali I Musani1* and Akrum Al-Zubaidi2Computed Tomography (CT), Magnetic Resonance Im-
aging (MRI), and X-rays have been very disappointing in
the detection and diagnosis of central (airways/endobron-
chial) lesions.
Bronchoscopy with direct visualization and other sup-
portive technologies has been the primary tool for the
detection and surveillance of endobronchial precancer-
ous and cancerous lesions. Early detection of lung can-
cer allows early interventions which has a survival
benefit as shown by a 20% relative decrease in lung can-
cer specific mortality with low-dose computed tomog-
raphy screening and high-risk groups [1]. CT screening
of the thorax is able to detect lesions that are peripheral,
central, and sub centimeter, however it is insensitive for
detection of precancerous and early small cancerous le-
sions arising from the airways.
The pathological progression from normal broncho-
genic epithelium to squamous metaplasia followed by
dysplasia and finally carcinoma in situ(CIS) is supported
by sputum cytology studies as well as animal data [2,3],
however other models such as multiple foci of precursor
lesions that are produced throughout the respiratory epi-
thelium may develop into carcinoma in situ as opposed
to a stepwise progression of a single area [4]. Regardless,
prompt detection of high-risk patients that offers early
diagnosis of preinvasive lesions could allow for early
intervention and improved survival.
The use of white light bronchoscopy is the standard
imaging tool for the diagnosis of central airway tumors.
However, in the detection of precancerous lesions WLB
has a low sensitivity and specificity [5,6]. Recent ad-
vances have allowed bronchoscopists to evaluate the air-
way with advanced high-resolution imaging modalities.
The development of the ideal bronchoscopic imaging
technique capable of detecting preinvasive lesions is
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article, unless otherwise stated.Currently autofluorescence bronchoscopy (AFB), narrow-
band imaging(NBI), high magnification bronchovideoscopy
(HMB), probe based confocal endomicroscopy (pCLE),
optical coherence tomography (OCT), radial probe
endobronchial ultrasonography (R-EBUS) and now high
definition bronchoscopy (HD) with surface enhancement
(i-scan) are all being studied or used in clinical practice to
evaluate the airway. The ideal system would be able to de-
tect and define preinvasive lesions so that not only are we
able to preemptively treat these lesions but determine ef-
fectiveness of treatment with noninvasive or minimally in-
vasive techniques.
In this issue of Respiratory Research, van der Heijden
and colleagues report a randomized blinded prospective
study, which examined the use of 5 videobronchoscopy
techniques in 29 patients in which the authors explore
whether different modalities might lead to improved
detection of suspicious vascular changes or suspected
preinvasive lesions.
In the previous literature, WLB combined with AFB
increased the diagnostic accuracy for squamous dyspla-
sia, CIS, and early lung cancer with a high sensitivity but
resulted in a large number of false positives and un-
needed biopsies [7,8]. Heijden and colleagues did show
that HD bronchoscopy with i-scan improve detection of
vascular changes over WLB and AFB however AFB did
detect more preinvasive lesions over WLB and HD
modes. Histological confirmation was not obtained in
this study so it is difficult to discern whether there
would be improved accuracy of HD modes over AFB.
That said we agree that it is likely that improved images
and image enhancement which are able to better identify
vascular abnormalities could improve overall diagnostic
yield.
Further studies in which a potential combination of
methods, which improve efficiency of the airway evalu-
ation while also improving accuracy of diagnosis are
needed to fully determine the clinical implications of
these modalities. Finally, the bigger question remains,
would early detection and treatment of precancerousd Central. This is an Open Access article distributed under the terms of the
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changes the ultimate outcomes in patients.
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